Yokogawa (6841.T)

Executive Summary

Yokogawa Life Science, a division of Yokogawa Electric Corporation, provides advanced instrumentation and digital solutions for biopharmaceutical research and manufacturing. Specializing in high-content imaging, single-cell analysis, flow imaging microscopy, and integrated automation platforms, the company supports drug discovery, regenerative medicine, and precision medicine. Leveraging over a century of industrial automation expertise, Yokogawa enables high-quality data generation and process control for the life sciences industry. The division targets the growing demand for digital and AI-driven tools in bioprocessing, where automation and real-time analytics are critical for accelerating development and improving yields.

Upcoming Catalysts (preview)

• Q3 2026Launch of next-generation high-content imaging system80% success
• H2 2026Strategic partnership with a top-20 pharma company for bioprocess automation60% success
• Q4 2026Expansion of AI/ML-based analytics platform into new geographic markets70% success